BioSig Technologies Stock Price, News & Analysis (NASDAQ:BSGM) $0.31 +0.00 (+0.91%) (As of 11:45 AM ET) Add Compare Share Share Today's Range$0.30▼$0.3250-Day Range$0.31▼$0.6352-Week Range$0.28▼$1.65Volume23,826 shsAverage Volume445,634 shsMarket Capitalization$27.31 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media BioSig Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,512.9% Upside$5.00 Price TargetShort InterestHealthy2.30% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.21Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.06 out of 5 starsMedical Sector760th out of 935 stocksElectromedical Equipment Industry17th out of 22 stocks 3.5 Analyst's Opinion Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, BioSig Technologies has a forecasted upside of 1,512.9% from its current price of $0.31.Amount of Analyst CoverageBioSig Technologies has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.30% of the outstanding shares of BioSig Technologies have been sold short.Short Interest Ratio / Days to CoverBioSig Technologies has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in BioSig Technologies has recently decreased by 13.98%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BSGM. Previous Next 4.0 News and Social Media Coverage News SentimentBioSig Technologies has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BioSig Technologies this week, compared to 0 articles on an average week.Search Interest5 people have searched for BSGM on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows2 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.30% of the stock of BioSig Technologies is held by insiders.Percentage Held by InstitutionsOnly 7.16% of the stock of BioSig Technologies is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioBioSig Technologies has a P/B Ratio of 31.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About BioSig Technologies Stock (NASDAQ:BSGM)BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More BSGM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSGM Stock News HeadlinesNovember 27, 2023 | msn.comBiosig Technologies (BSGM) Price Target Increased by 38.89% to 5.74November 18, 2023 | americanbankingnews.comHead to Head Review: BioSig Technologies (NASDAQ:BSGM) and Semler Scientific (NASDAQ:SMLR)November 28, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 9, 2023 | msn.comBioSig announces $2.5M registered direct offering priced at-the-market under Nasdaq rulesNovember 9, 2023 | finance.yahoo.comBioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesSeptember 6, 2023 | benzinga.comBioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are TreatedAugust 25, 2023 | finance.yahoo.comBioSig (BSGM) Grows in Arrhythmia Care With Subscription ModelAugust 24, 2023 | finance.yahoo.comBioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for HospitalsNovember 28, 2023 | Edge On The Street (Ad)Americans Now Favor Gold Over Stocks as an Investment VehicleAmericans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges. August 16, 2023 | finance.yahoo.comBioSig Technologies Second Quarter 2023 Earnings: US$0.16 loss per share (vs US$0.15 loss in 2Q 2022)July 25, 2023 | finance.yahoo.comBioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence ApplicationsJuly 21, 2023 | finance.yahoo.comNVIDIA Inception Chooses BioSig AI For Innovation In Healthcare AI, An Industry That Is Projected To Reach $272.9 Billion By 2030July 20, 2023 | theglobeandmail.comHealthcare Shares Bid Up Following Major Premarket AnnouncementJuly 20, 2023 | markets.businessinsider.comWhy Is BioSig Technologies (BSGM) Stock Up 19% Today?July 20, 2023 | finance.yahoo.comBioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for HospitalsJune 29, 2023 | finance.yahoo.comBioSig Joins Webull Corporate ConnectJune 27, 2023 | finance.yahoo.comBioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for HealthcareMay 24, 2023 | benzinga.comNew Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation MarketMay 19, 2023 | finance.yahoo.comNew Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating ArrhythmiasMay 16, 2023 | investing.comBiosig Tech (BSGM) Earnings Dates & ReportsMarch 27, 2023 | finance.yahoo.comBioSig Announces New Advisory Board Member Edwin WangMarch 24, 2023 | finance.yahoo.comBioSig Announces New Advisory Board Member Lorraine SpurgeMarch 13, 2023 | finance.yahoo.comBioSig Confirms No Exposure to Silicon Valley BankFebruary 22, 2023 | finance.yahoo.comBioSig Regains Compliance With All Nasdaq Listing StandardsFebruary 22, 2023 | finance.yahoo.comBioSig Regains Compliance With All Nasdaq Listing StandardsFebruary 17, 2023 | finance.yahoo.comBioSig Awarded US Patent Claims for its Universal Notch Filter TechnologyFebruary 7, 2023 | msn.comBioSig names Steve Buhaly CFO replacing ChaussySee More Headlines Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2022Today11/28/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees47Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+1,527.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,050,000.00 Net Margins-9,336.04% Pretax Margin-20,963.12% Return on Equity-8,125.85% Return on Assets-727.39% Debt Debt-to-Equity RatioN/A Current Ratio0.27 Quick Ratio0.21 Sales & Book Value Annual Sales$290,000.00 Price / Sales93.34 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book30.72Miscellaneous Outstanding Shares88,110,000Free Float79,914,000Market Cap$27.07 million OptionableNot Optionable Beta1.29 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Kenneth L. Londoner M.B.A. (Age 55)Founder, CEO & Executive Chairman Comp: $1.17MMr. John Sieckhaus (Age 55)Chief Operating Officer Comp: $282.52kMr. Michael Graydon Fleming Jr. (Age 49)Chief Commercial Officer Comp: $400kMr. Frederick D. Hrkac (Age 57)Executive VP & Director Comp: $15kMr. Steven J. Buhaly (Age 66)Chief Financial Officer Dr. Budimir S. Drakulic Ph.D. (Age 73)Chief Scientist Comp: $169.64kMr. Andrew Gornell BallouVice President of Investor RelationsMs. Brenda CastrodadVice President of Human ResourcesMore ExecutivesKey CompetitorselectroCoreNASDAQ:ECORPrecision OpticsNASDAQ:POCINeurAxisNASDAQ:NRXSVivani MedicalNASDAQ:VANINocturne AcquisitionNASDAQ:MBTCView All CompetitorsInsiders & InstitutionsWarberg Asset Management LLCBought 30,928 shares on 11/13/2023Ownership: 0.085%Group One Trading L.P.Bought 100 shares on 11/9/2023Ownership: 0.000%PFG Investments LLCBought 63,500 shares on 11/6/2023Ownership: 0.192%Advisor Resource CouncilBought 176,700 shares on 10/25/2023Ownership: 1.439%Kenneth L LondonerBought 6,000 shares on 6/12/2023Total: $7,020.00 ($1.17/share)View All Insider TransactionsView All Institutional Transactions BSGM Stock Analysis - Frequently Asked Questions Should I buy or sell BioSig Technologies stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares. View BSGM analyst ratings or view top-rated stocks. What is BioSig Technologies' stock price target for 2024? 2 brokers have issued twelve-month price objectives for BioSig Technologies' stock. Their BSGM share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,512.9% from the stock's current price. View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts. How have BSGM shares performed in 2023? BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has decreased by 26.2% and is now trading at $0.31. View the best growth stocks for 2023 here. When is BioSig Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our BSGM earnings forecast. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 8,125.85%. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU). Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Advisor Resource Council (1.44%), PFG Investments LLC (0.19%), Warberg Asset Management LLC (0.09%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:BSGM) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.